This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026.
The contract was competitively solicited without any set-asides. It is estimated that over 19,000 bottles of clozapine tablets in various strengths will be provided annually to support the healthcare needs of veterans, military personnel, federal inmates, and Native American populations served by these government agencies. Mylan has a history of providing specialty drug products to federal customers, including prior IDC awards for medications used to treat mental health, cardiovascular, and neurological conditions. This contract is a continuation of Mylan's role as a prime vendor under the VA Pharmaceutical Prime Vendor program, facilitating the distribution of critical pharmaceuticals to VA, DoD, BOP, and IHS facilities nationwide.
Generated 1/26/25, 12:00 AM